the cryo-EM
Latest paper from the lab: the cryo-EM structure of BeeRA family of bacterial actin homologues forms a 3-stranded tubular structure…
Investor Funding Oversubscribed
Prosemble proudly announces that its initial angel investor funding round has been oversubscribed. This strong support underscores confidence in our mission to transform precision therapies.
Immunogenicity/Tox Studies Collaboration
Prosemble begins Immunogenicity/Tox Studies, including Toxicity Study in NCG immunodeficient mice, in collaboration with TransCure BioServices. Exciting progress ahead!
the AI in Health
General announcement: Excited to join the AI in Health Accelerator Programme! Over the next few months, we’ll be working closely with…
New insights into actin filament diversity
The cytoskeleton is essential for cell organisation and movement, with actin filaments in eukaryotes and actin-like proteins in bacteria playing key roles.
Angel Investor Funding
Prosemble is pleased to announce the successful completion of its angel investor funding round. This milestone marks a significant step forward in advancing our mission to revolutionise precision therapies.